• Nikkei Stock Average Futures Price Limit Offset Levels Revised

      • To
      • Members, Member Firms and Market Users
      • From
      • Research and Product Development
      • #
      • SER-6830
      • Notice Date
      • 10 September 2013
      • Effective Date
      • 23 September 2013
    • Effective on trade date September 23, 2013, a new price limit and trading halt methodology will be in effect for Nikkei Stock Average Futures, Yen Denominated Nikkei Stock Average Futures, and E-mini Yen Denominated Nikkei Stock Average Futures.
       
      The Offset Levels for the determination of Nikkei Stock Average futures price limits are revised to the following levels, effective as of the commencement of Electronic Trading Hours (ETH) on Sunday, September 22, 2013, at 5:00 p.m. Chicago time. These offset levels shall be in force until the close of trading on Friday, November 29, 2013. The Price Limit Offset Levels are as follows:  
       
       
      September 2013 through November 2013 Nikkei Futures Offset Levels
      Contracts
      8% Up and Down Offsets
       
      12% Up and Down Offsets
       
      16% Up and Down Offsets
       
      Nikkei Stock Average Futures
      1,100.00
      1,650.00
      2210.00
      Yen Denominated Nikkei Stock Average Futures
      1,100.00
      1,650.00
      2210.00
      E-mini Yen Denominated Nikkei Stock Average Futures
      1,100.00
      1,650.00
      2210.00
       
      Exchange Rules call for the Offset Levels to be re-calculated every three months at the end of February, May, August and November preceding the commencement of the next three month period. The three month periods include: March through May; June through August; September through November; and December through February.
       
                 
      Please consult the CME Rulebook for a complete description of the application of the price limit and trading halt provisions for Nikkei Stock Average Futures. Or, you may wish to direct any inquiries to John Nyhoff, Research & Product Development at 312-930-231, or Lucy Wang, Research & Product Development at 312-648-5478.
       
      © Copyright CME Group. All rights reserved.